House bill proposes changes to 340B drug pricing rules
/ 1 min read
Table of Contents
A bill titled the 340B PATIENTS Act of 2025 was introduced in the U.S. House of Representatives. It has been referred to the House Committee on Energy and Commerce.
Why it matters: This is a legislative proposal, not a final rule or law. Its practical significance depends entirely on whether it passes. If enacted, it could alter the financial models of thousands of safety-net clinics and the pricing structures of pharmaceutical manufacturers. Until it moves further through the legislative process, it does not change any current obligations or benefits.
Who it affects
- Safety-net health centers and hospitals participating in the 340B program
This information is based on the Congressional Record from Congress.gov; readers should check the full bill text and committee actions before relying on it for compliance or financial planning.
Agency: House
Source: Congress.gov — read the official document